Update on prescription extended-release opioids and appropriate patient selection.
about
Effectiveness and tolerability of transdermal buprenorphine patches: a multicenter, prospective, open-label study in Asian patients with moderate to severe chronic musculoskeletal painUse of immediate-release opioids as supplemental analgesia during management of moderate-to-severe chronic pain with buprenorphine transdermal system.Update on extended-release opioids in pain management.Extending Time Profile of Morphine-Induced Analgesia Using a Chitosan-Based Molecular Imprinted Polymer Nanogel.Effect of food on the pharmacokinetics of oxycodone and naltrexone from ALO-02, an extended release formulation of oxycodone with sequestered naltrexone.Attenuating the Agent: Reducing Opioid “Virulence”
P2860
Update on prescription extended-release opioids and appropriate patient selection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Update on prescription extended-release opioids and appropriate patient selection.
@en
Update on prescription extended-release opioids and appropriate patient selection.
@nl
type
label
Update on prescription extended-release opioids and appropriate patient selection.
@en
Update on prescription extended-release opioids and appropriate patient selection.
@nl
prefLabel
Update on prescription extended-release opioids and appropriate patient selection.
@en
Update on prescription extended-release opioids and appropriate patient selection.
@nl
P2860
P356
P1476
Update on prescription extended-release opioids and appropriate patient selection.
@en
P2093
Michael J Brennan
P2860
P304
P356
10.2147/JMDH.S38562
P577
2013-07-23T00:00:00Z